# Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer

> **NCT00702182** · PHASE1 · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 30 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Vinorelbine (Navelbine)
- **DRUG:** Vinorelbine (Navelbine)
- **DRUG:** Erlotinib

## Key facts

- **NCT ID:** NCT00702182
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2012-04
- **Final completion:** 2012-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702182, "Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00702182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*